Total Revenues in the first nine months of 2024 increased by $300 million compared to same period in 2023, to $339 million, with Q3 revenues contributing $103 millionProduct revenues in the first nine ...
The Standard & Poor’s Biotechnology Select Industry Index (XBI), one measure of the health of the life sciences industry, ...
The expansion is aimed at advancing the health innovation incubator's mission of supporting transformative healthcare ...
ALBANY – Albany State University has announced the launch of a new Master of Science in Integrated Biotechnology program, set to begin in spring 2025. This degree is designed to prepare students for a ...
The Washington State Employment Security Department said in the filing that 72 employees will be laid off on Jan. 17. A ...
JP Morgan initiated coverage on Blueprint Medicines Corporation (NASDAQ:BPMC), a biotech company focused on modulating immune ...
BAY HARBOR ISLAND, Fla. (AP) — BAY HARBOR ISLAND, Fla. (AP) — Fortress Biotech Inc. (FBIO) on Thursday reported a loss of $12.9 million in its third quarter. On a per-share basis, the Bay Harbor ...
On STAT's podcast, hear about what happened with AbbVie's schizophrenia drug, Amgen's obesity drug and what might happen at ...
Sagimet Biosciences eyes major opportunities in MASH and Acne treatments. Find out why SGMT stock is a solid pick with upcoming phase 3 study results.
Zacks.com on MSN8h
Biotech Stock Roundup: NVAX Q3 Results, SNDX Down on AML Data, RNA Surges on Study DataAs the third-quarter earnings season ends this week, the focus in the biotech sector is mostly on pipeline and key regulatory ...
Germany’s Evotec SE is attracting potential takeover interest from Nasdaq-listed biotech firm Halozyme Therapeutics Inc., ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback